Fulcrum Therapeutics, Inc. logo FULC - Fulcrum Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 4
SELL 1
STRONG
SELL 0
| PRICE TARGET: $20.67 DETAILS
HIGH: $25.00
LOW: $10.00
MEDIAN: $23.50
CONSENSUS: $20.67
UPSIDE: 214.61%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 27.40
Quick Ratio 27.40
Solvency Ratio -4.252
Cash Ratio 15.14

Valuation Ratios

Ratio Value
Price/Earnings
-9.57
Peers avg: 26.3
PEG Ratio -0.02
Forward PEG -0.02
Price/Book 2.05
Price/Sales 0.00
Price/FCF -11.87
Price/Op Cash Flow -11.93

Debt Ratios

Ratio Value
Debt/Assets 0.0176
Debt/Equity 0.0185
Debt/Capital 0.0181
Long-Term Debt/Capital 0.0114
Financial Leverage 1.05

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.603
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.5%

Coverage Ratios

Ratio Value
Debt Service Coverage -30.57
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -24.99
Operating Cash Flow Coverage -9.32
Capital Expenditure Coverage -191.29
Dividend + Capital Expenditure Coverage -191.29

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.182
Debt/Share 0.1017
Cash/Share 5.56
Book Value/Share 5.51
Tangible BV/Share 5.51
Equity/Share 5.51
Operating Cash Flow/Share -0.948
Capital Expenditure/Share 0.005
FCF/Share -0.953

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.883
Price/Fair Value 2.05
Debt/Market Cap 0.0090
Effective Tax Rate 0.0%
Enterprise Value Multiple -7.15